Stock screenerAll disclosures →
EDGAR →
RANI
Conviction 12HealthcareScan · Thu, Jun 25, 2026RANI$0.7395-3.59%
ResistanceSupportVol 14Vol MA14 644.43K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price0.7395
Change-3.59%
Gap+2.02%
Rel volume0.27×
Avg volume803.27K
Avg $ vol671.7K
SMA 200.8182
SMA 500.9089
SMA 2001.18
Price vs 50-18.64%
Price vs 200-37.07%
MA stackbearish
50/200 cross—
Supertrenddown · 0.9249
RSI (14)36
MACD hist-0.00
MACD cross—
Stoch %K / %D6 / 12
ADX (14)17
+DI / −DI17 / 24
RSI divergence—
MACD divergence—
ATR %+8.26%
ADR %6.67%
52w high2.85
52w low0.4100
From 52w high-74.05%
Above 52w low+80.37%
New 52w highNo
SqueezeOff
Bollinger width31.50%
%B0.19
Donchian pos3.62%
Donchian high0.9923
Donchian low0.7300
AVWAP (52w high)1.85
vs AVWAP high-60.10%
AVWAP (52w low)1.89
vs AVWAP low-60.97%
OBV trendDown
Chaikin MF (20)-0.30
Today vs 20d0.27×
Avg vol (14d)644.43K
Avg vol (20d)803.27K
Avg $ vol (20d)671.7K
Market cap48.91K
RS 3m (vs SPY)-39.90%
RS 6m (vs SPY)-56.94%
RS line new highNo
Trend template3/8
Technical rank8.5
1 week-3.36%
1 month-21.37%
3 months-35.13%
6 months-50.37%
1 year+48.85%
YTD-45.62%
P/E-0.00
P/B0.00
P/S0.03
P/FCF-0.00
EPS-0.4500
Div yield—
ROE-104.46%
ROA-57.20%
Debt/Eq0.00
Current3.40
EV/EBITDA—
Gross margin—
Net margin—
Rev growth58.85%
EPS growth1.15%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-9.6M
Revenue1.71M
Net income-7.03M
Gross profit—
Free cash flow-18.8M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out99.91M
Employees69
ListedFri, Jul 30, 2021
Free float73.33M
Float %75.2%
Short interest7.38M
Days to cover5.7d
Short volume55.9%
Squeeze score56 / 100
Next earningsThu, Aug 6, 2026 (42d)
EPS forecast−$0.05 · 1 est
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction12 / 100
Pattern quality—
Tech rank8.5 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance1.13
Support0.7750
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in RANI
No recent disclosed trades by Congress in RANI. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in RANI · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Javadi Alireza Chief Technical Officer · Stock Option (Right to Buy) · 2026-06-03 | Grant | 805.5K | $0 | 2026-06-03 | 2026-06-05 |
Imran Talat Chief Executive Officer · Stock Option (Right to Buy) · 2026-06-03 | Grant | 3.8M | $0 | 2026-06-03 | 2026-06-05 |
McKinley Kate Chief Business Officer · Stock Option (Right to Buy) · 2026-06-03 | Grant | 805.5K | $0 | 2026-06-03 | 2026-06-05 |
Bassan Abraham Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
Bailey Vasudev Jaiprakash Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
Rometty Lisa Ann Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
BUTEL JEAN LUC Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
Ausiello Dennis A Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
IMRAN MIR A Director · Director Stock Option (Right to Buy) · 2026-05-28 | Grant | 123.6K | $0 | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in RANI
No recent SEC filings on file for RANI.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.